IP Library Granted Patent US 11,085,064
Granted Patent B2
US 11,085,064 · App. 16/805,390 · Granted Aug 10, 2021

Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing

Inventors: Austin Ashby (Tucson, AZ); Wayne Showalter (Tucson, AZ); Jasmin Cote (Quebec, CA)
Assignee: Accelerate Diagnostics, Inc.
C12Q1/025B01L3/527C12Q1/04G01N1/38G01N15/06G01N21/6458G01N35/025G01N35/1002G02B7/28B01L2300/0893G01N2015/0693G01N2021/6419G01N2035/00346G01N2035/0443G01N2035/0444G01N2035/0446G01N2035/0455G01N2035/1032
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,085,064
App. No.
16/805,390
Granted
Aug 10, 2021
Kind
B2
Abstract

A system for automated microorganism identification and antibiotic susceptibility testing comprising a reagent cartridge, a reagent stage, a cassette, a cassette, stage, a pipettor assembly, an optical detection system, and a controller is disclosed. The system is designed to dynamically adjust motor idle torque to control heat load and employs a fast focus process for determining the true focus position of an individual microorganism. The system also may quantify the relative abundance of viable microorganisms in a sample using dynamic dilution, and facilitate growth of microorganisms in customized media for rapid, accurate antimicrobial susceptibility testing.

Claims (18)

1. A system comprising:

a system controller comprising:

a processor; and

a computer-readable storage medium storing instructions that, when executed by the processor, cause the system controller to perform operations comprising:

extracting three or more subsamples from a sample comprising cells of a species of microorganism;

diluting each subsample using a distinct dilution factor for each subsample;

determining a cell concentration of each diluted subsample;

approximating a non-linear effective dilution curve for the sample using the subsample cell concentrations and the distinct dilution factors;

determining from the non-linear effective dilution curve a target dilution factor usable in diluting the sample to a target cell concentration; and

diluting a portion of the sample using the determined target dilution factor.

2. The system of claim 1 , wherein the determining a cell concentration of each diluted subsample further comprises a counting of a number of cells present in each diluted sub sample.

3. The system of claim 1 , wherein approximating a non-linear effective dilution curve for the sample further comprises determining an average subsample cell concentration by multiplying each subsample cell concentration by its corresponding sample dilution factor raised to a power of a proportionality constant to obtain a mathematical product, summing the mathematical products to obtain a sum, and dividing the sum by the number of sub samples.

4. The system of claim 1 , wherein the operations performed by the system controller further comprise adjusting the determined target dilution factor with a growth factor associated with the species of microorganism prior to diluting a portion of the sample to the target cell concentration.

5. The system of claim 4 , wherein the growth factor accounts for the rate of growth of the species of microorganism and a rate of nonviable cells in the sample.

6. The system of claim 4 , wherein the growth factor is determined empirically for each microorganism.

7. The system of claim 1 , wherein approximating a non-linear effective dilution curve for the sample comprises plotting dilution test points on an x/y plot, wherein each dilution test point comprises a subsample cell concentration and a corresponding sample dilution factor used to dilute the subsample.

8. The system of claim 7 , wherein approximating a non-linear effective dilution curve for the sample further comprises interpolating between the dilution test points by performing at least one of multiple linear interpolations or multiple spline interpolations between the dilution test points, and creating a model of the non-linear effective dilution curve using the multiple interpolations.

9. The system of claim 8 , wherein interpolating between multiple dilution test points comprises identifying a first of the dilution test points with a subsample cell concentration that, when adjusted by a growth factor associated with the species of microorganism, is less than the target cell concentration; identifying a second of the dilution test points with a subsample cell concentration that, when adjusted by the growth factor, is greater than or equal to the target cell concentration, and using an interpolation between the first and second identified dilution test points to determine the target dilution factor.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 30, 2026
From: AST REVOLUTION, LLC
To: ELITECHGROUP INC.
Reel/Frame 074217/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2025
From: ACCELERATE DIAGNOSTICS, INC.; ACCELERATE DIAGNOSTICS TEXAS, LLC.
To: AST REVOLUTION, LLC
Reel/Frame 072314/0691 →
SECURITY INTEREST Recorded Aug 8, 2024
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 068222/0638 →
SECURITY INTEREST Recorded May 16, 2024
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 067430/0886 →
SECURITY INTEREST Recorded Jun 9, 2023
From: ACCELERATE DIAGNOSTICS, INC.
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 063912/0050 →
Continuity (9)
Continuation 16297356 · Mar 8, 2019
Division 15849297 · Dec 20, 2017
Division 15085953 · Mar 30, 2016
Provisional Application 62268340 · Dec 16, 2015
Provisional Application 62260085 · Nov 25, 2015
Provisional Application 62194142 · Jul 17, 2015
Provisional Application 62152773 · Apr 24, 2015
Provisional Application 62140300 · Mar 30, 2015
Related Publication 20200370086A1 · Nov 26, 2020